Arno Velds

Arno Velds

Auto-generated profile, based on publicly available information

Arno Velds

Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Cell
Verified
Journal Article
Closed access
SNSebastian M.B. Nijman
Sebastian M.B. Nijman
MLMark P.A. Luna-Vargas
Mark P.A. Luna-Vargas
AVArno Velds
Arno Velds
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
ADAnnette M.G. Dirac
Annette M.G. Dirac
RBRené Bernards
René Bernards

25 March 2004 in Nature
Verified
Journal Article
Closed access
PDF file
KBKatrien Berns
Katrien Berns
EHE. Marielle Hijmans
E. Marielle Hijmans
JMJasper Mullenders
Jasper Mullenders
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
AVArno Velds
Arno Velds
RBRené Bernards
René Bernards

10 November 2013 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
NRNienke van Rooij
Nienke van Rooij
MBMarit M. van Buuren
Marit M. van Buuren
DPDaisy Philips
Daisy Philips
AVArno Velds
Arno Velds
MTMireille Toebes
Mireille Toebes
TSTon N. Schumacher
Ton N. Schumacher

22 December 2014 in Nature Medicine
Verified
Journal Article
Closed access
CLCarsten Linnemann
Carsten Linnemann
MBMarit M van Buuren
Marit M van Buuren
LBLaura Bies
Laura Bies
EVEls M E Verdegaal
Els M E Verdegaal
RSRemko Schotte
Remko Schotte
TSTon N M Schumacher
Ton N M Schumacher

17 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
XLXiaoling Liu
Xiaoling Liu
HHHenne Holstege
Henne Holstege
HGHanneke van der Gulden
Hanneke van der Gulden
MTMarcelle Treur-Mulder
Marcelle Treur-Mulder
JZJohn Zevenhoven
John Zevenhoven
JJJos Jonkers
Jos Jonkers
Women carrying germ-line mutations in BRCA1 are strongly predisposed to developing breast cancers with characteristic features also observed in sporadic basal-like breast cancers. They appear as high-grade tumors with high proliferation rates and pushing borders. On the molecular level, they are negative for hormone receptors and ERBB2, display frequent TP53 mutations, and express basal epithelial markers. To study the role of BRCA1 and P53 loss of function in breast cancer development, we generated conditional mouse models with tissue-specific mutation of Brca1 and/or p53 in basal epithelial cells. Somatic loss of both BRCA1 and p53 resulted in the rapid and efficient formation of highly proliferative, poorly differentiated, estrogen receptor-negative mammary carcinomas with pushing borders and increased expression of basal epithelial markers, reminiscent of human basal-like breast cancer. BRCA1- and p53-deficient mouse mammary tumors exhibit dramatic genomic instability, and their molecular signatures resemble those of human BRCA1 -mutated breast cancers. Thus, these tumors display important hallmarks of hereditary breast cancers in BRCA1 -mutation carriers.

3 May 2013 in Science
Verified
Journal Article
Closed access
PDF file
CGCarmen Gerlach
Carmen Gerlach
JRJan C. Rohr
Jan C. Rohr
LPLeïla Perié
Leïla Perié
NRNienke van Rooij
Nienke van Rooij
JHJeroen W. J. van Heijst
Jeroen W. J. van Heijst
TSTon N. M. Schumacher
Ton N. M. Schumacher
Dynamic Protection: During an immune response, CD8 + T cells are recruited to provide protection. Most cells differentiate into short-lived effectors that help to clear the pathogen, whereas others form long-lived memory cells to protect against reinfection. Gerlach et al. (p. 635 , published online 14 March) and Buchholz et al. (p. 630 , published online 14 March) used in vivo fate mapping of mouse T cells with a defined specificity during a bacterial infection to show that the dynamics of the single-cell response are not uniform. The response of a particular T cell population is the average of a small number of clones that expand greatly (“large clones”) and many clones that only proliferate at low amounts (“small clones”). The memory pool arises largely from small clones whereas effectors are primarily made up of large clones.